lencana Anda Rentang 52M $16–$110 82% of range Peringkat Analis STRONG BUY 23 analysts Target Harga $120 +29% upside P/E 29.1 ROE -26.5% Margin Laba Bersih ·

SYRE Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $93.19
Kapitalisasi Pasar (MRQ) $8.21B
P/E 29.1
EPS $13.76
Pendapatan $0
ROE -26.5%
Rentang 52M $16–$110

SYRE Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 1
Tanggal ex-dividen Pemecahan Tipe
8 Sep. 2023 1-for-25 Terbalik

Tentang Spyre Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata
sektorHealthcare industriBiotechnology karyawan125 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$0
2016-12-31 → 2025-12-31
EPS$13.76
2020-12-31 → 2023-12-31
Arus Kas Bebas·
2016-12-31 → 2024-12-31
Margin bersih·
2018-12-31 → 2023-12-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun SYRE rata-rata 5T Median Rekan Kesimpulan
P/E 29.1rata-rata 5T ≈2.7 ≈2.7 · ·
P/B (MRQ) 7.5rata-rata 5T ≈22.7 ≈22.7 7.1 Nilai wajar
Price / Cash Flow (Harga / Arus Kas) -43.4rata-rata 5T ≈-35.6 ≈-35.6 · ·
Price / Tangible Book (Harga / Nilai Buku Berwujud) 10.3rata-rata 5T ≈19.0 ≈19.0 · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata 27.7%
Laporan Berikutnya Nov 02, 2026
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 Agu 3, 2026 $-0.36 $-0.77 53.5%
31 Maret 2026 Mei 7, 2026 $-0.74 $-0.68 -8.9%
31 Des. 2025 $-0.70 $-0.79 11.4%
30 Sep. 2025 $-0.15 $-0.76 80.3%
30 Juni 2025 $-0.77 $-0.77 -0.17%
31 Maret 2025 $-0.60 $-0.86 30.1%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 14
Metrik Tren 2025202420232022202120202019201820172016
Revenue $0$0$886.0K$2M$19M$0$0$4M$5M$5M
R&D Expense ···$59M$57M$60M$65M$37M$23M$18M
SG&A Expense $48M$46M$40M$29M$27M$22M$16M$13M$10M$8M
Operating Expenses $210M$209M$243M$87M$84M$81M$80M$49M$33M$27M
Operating Income $-210M$-209M$-242M$-85M$-66M$-81M$-80M$-45M$-28M$-22M
Other Non-op $29M$-21M$-19M$-7.0K$-122.0K$-5.0K$-63.0K$-57.0K$-42.0K$-36.0K
Pretax Income $-155M$-208M$-339M$-84M$-66M$-81M$-78M···
Income Tax $-15.0K$51.0K$-26.0K$-136.0K$141.0K$0$0$0$0$0
Net Income $-155M$-208M$-339M$-84M$-66M$-81M$-78M$-44M$-27M$-22M
EPS (Basic) ··$13.76$-24.86$-25.02$-1.52····
EPS (Diluted) ··$13.76$-24.86$-25.02$-1.52····
Shares (Basic) ··6,897,0653,371,2312,629,78453,371,730····
Shares (Diluted) ··6,897,0653,371,2312,629,78453,371,730····
EBITDA $-210M$-209M$-242M$-83M$-64M$-80M$-80M$-45M$-27M$-22M
Neraca 21
Metrik Tren 2025202420232022202120202019201820172016
Cash & Equivalents $86M$89M$189M$35M$15M$90M$19M$22M$13M$48M
Short-term Investments ·······$52M$37M$16M
Prepaid Expense $21M$5M$2M$6M$5M$4M$3M$2M$2M$2M
Current Assets $778M$608M$342M$62M$99M$150M$75M$77M$55M$66M
PP&E (Net) ··$0$3M$5M$6M$2M$1M$854.0K$599.0K
PP&E (Gross) ··$0$7M$7M$8M$3M$2M$1M$839.0K
Accum. Depreciation ··$0$4M$3M$2M$1M$752.0K$487.0K$240.0K
Other Non-current Assets $0$10.0K$9.0K$683.0K$842.0K$115.0K$67.0K$50.0K$232.0K$40.0K
Total Assets $778M$608M$342M$71M$110M$162M$83M$78M$56M$67M
Accounts Payable ···$677.0K$3M$2M$3M$663.0K$389.0K$168.0K
Current Liabilities $59M$54M$32M$15M$20M$16M$18M$10M$6M$4M
Capital Leases ··$0$4M$5M$5M$5M···
Other Non-current Liabilities $0··$0$16.0K$214.0K$31.0K$72.0K$111.0K$132.0K
Total Liabilities $63M$91M$73M$21M$26M$22M$23M$10M$6M$4M
Common Stock $15.0K$13.0K$10.0K$6.0K$5.0K$5.0K$3.0K$2.0K$2.0K$1.0K
Paid-in Capital ·······$184M$123M$108M
Retained Earnings $-1.13B$-972M$-764M$-426M$-342M$-276M$-195M$-117M$-73M$-45M
AOCI $869.0K$180.0K$302.0K$-48.0K$-20.0K$11.0K$51.0K$-27.0K$-102.0K$-4.0K
Stockholders' Equity $715M$518M$184M$50M$84M$140M$60M$67M$50M$63M
Liabilities + Equity $778M$608M$342M$71M$110M$162M$83M$78M$56M$67M
Shares Outstanding 78,189,81160,257,00036,057,0002,614,0001,974,0001,918,00029,084,43724,140,09716,670,18813,430,833
Arus Kas 12
Metrik Tren 2025202420232022202120202019201820172016
D&A $0$0$744.0K$2M$2M$996.0K$418.0K$293.0K$249.0K$132.0K
Stock-based Comp $38M$45M$26M$7M$8M$6M$5M$4M$2M$1M
Other Non-cash $-52M$6M$212M$-5M$2M$-2M$7M$8M$-120.0K$2M
Operating Cash Flow $-169M$-157M$-100M$-80M$-54M$-76M$-66M$-32M$-25M$-19M
CapEx ·$0$0$38.0K$573.0K$4M$1M$422.0K$619.0K$212.0K
Investing Cash Flow $-143M$-353M$-108M$57M$-23M$-8M$-2M$-15M$-23M$-12M
Stock Issued ··$85M$0$0·····
Net Stock Activity ··$85M·······
Financing Cash Flow $309M$411M$361M$43M$1M$155M$66M$57M$12M$49M
Net Change in Cash $-4M$-100M$153M$19M$-75M$71M$-2M$10M$-35M$18M
Taxes Paid $-15.0K·········
Free Cash Flow ·$-157M$-100M$-80M$-54M$-80M$-67M$-33M$-25M$-19M
Profitabilitas 7
Metrik Tren 2025202420232022202120202019201820172016
Operating Margin ··-27348.0%-3640.2%-350.3%··-1169.3%··
Net Margin ··-38238.2%-3598.7%-351.1%··-1140.6%··
Pretax Margin ··-38241.1%-3604.6%-350.4%·····
EBITDA Margin ··-27264.0%-3573.0%-341.9%··-1161.8%··
ROA -22.4%-43.8%·-92.6%-48.5%-66.1%-97.3%-66.3%-44.2%-41.0%
ROE -26.5%-49.2%·-142.2%-70.8%-58.6%-111.9%-67.7%-48.1%-106.5%
ROIC -29.3%-40.3%·-168.3%-78.4%·····
Likuiditas & Solvabilitas 2
Metrik Tren 2025202420232022202120202019201820172016
Current Ratio 13.311.3·4.24.99.14.17.59.816.8
Quick Ratio 1.51.7·2.40.85.51.07.38.916.0
Efisiensi 1
Metrik Tren 2025202420232022202120202019201820172016
Asset Turnover 0.00.0·0.00.10.00.00.1··
Per Saham 5
Metrik Tren 2025202420232022202120202019201820172016
Book Value / Share $9.15$8.59·$0.77$1.70$2.92$2.07$2.79$3.02$4.69
Revenue / Share ··$0.13$0.03······
Cash Flow / Share ··$-14.49$-0.95······
Cash / Share $1.10$1.48·$0.53$0.31$1.88$0.66$0.93$0.77$3.56
EPS (TTM) $3.23$3.23$13.76$-24.86$-25.02$-1.52····
Tingkat Pertumbuhan 1
Metrik Tren 2025202420232022202120202019201820172016
Revenue YoY ··-62.0%-87.6%······
Valuasi (TTM) 10
Metrik Tren 2025202420232022202120202019201820172016
Revenue TTM $0$0$886.0K$2M$19M$0$0$4M$5M$5M
Net Income TTM $-155M$-208M$-339M$-84M$-66M$-81M$-78M$-44M$-27M$-22M
Market Cap $2.56B$1.40B·$735M$5.86B$9.44B$5.56B$4.52B$2.25B$1.46B
P/E 10.17.21.6-0.5-4.7-129.4····
P/S ···315.7312.8··1162.6433.2315.6
P/B 3.62.7·14.669.867.592.567.044.823.2
P / Tangible Book 3.62.74.214.669.867.5····
P / Cash Flow -15.1-8.9·-9.2-109.1-124.5-84.6-140.4-91.6-77.5
P / FCF ·-8.9·-9.2-108.0-117.9-82.7-138.6-89.3-76.7
Earnings Yield 9.9%13.9%63.9%-221.0%-21.1%-0.77%····

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $0 $0 $886.0K $2M $19M
Margin Operasi % · · -27348.0% -3640.2% -350.3%
Laba Bersih $-155M $-208M $-339M $-84M $-66M
EPS Dilusian · · $13.76 $-24.86 $-25.02

Pemilik institusional (13F) 277 pengaju · $8.3B total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 277
Nilai yang dipegang $8.3B
Posisi baru 94
Posisi yang keluar 21
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
94 (+34 vs Kuartal sebelumnya) 21 (+10 vs Kuartal sebelumnya) 105 (+38 vs Kuartal sebelumnya) 56 (+8 vs Kuartal sebelumnya) +11.3M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
FMR LLC $1.156.464.882 13.026.187 13,95% Saham
BlackRock, Inc. $577.656.391 6.506.605 6,97% Saham
PERCEPTIVE ADVISORS LLC $383.484.855 4.319.496 4,63% Saham
RTW INVESTMENTS, LP $377.492.205 4.251.996 4,55% Saham
Paradigm Biocapital Advisors LP $340.984.271 3.840.778 4,11% Saham
VANGUARD CAPITAL MANAGEMENT LLC $306.173.899 3.448.681 3,69% Saham
STATE STREET CORP $271.437.392 3.057.416 3,27% Saham
Venrock Adviser, LLC $265.048.073 2.985.448 3,20% Saham
Driehaus Capital Management LLC $248.509.957 2.799.166 3,00% Saham
GEODE CAPITAL MANAGEMENT, LLC $239.258.122 2.562.265 2,89% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $206.866.100 2.330.098 2,50% Saham
Capital World Investors $205.574.795 2.315.553 2,48% Saham
TCG Crossover Management, LLC $168.733.670 1.900.582 2,04% Saham
TANG CAPITAL MANAGEMENT LLC $167.989.516 1.892.200 2,03% Saham
BANK OF AMERICA CORP /DE/ $157.837.878 1.777.854 1,90% Saham
ADAGE CAPITAL PARTNERS GP, L.L.C. $152.905.794 1.722.300 1,84% Saham
WELLINGTON MANAGEMENT GROUP LLP $140.406.014 1.581.505 1,69% Saham
VANGUARD GROUP INC $132.189.024 4.035.074 1,59% Saham
GOLDMAN SACHS GROUP INC $131.222.079 1.478.059 1,58% Saham
FRANKLIN RESOURCES INC $130.767.861 1.472.943 1,58% Saham
Remedium Capital Partners, LLC $129.988.924 1.464.169 1,57% Saham
Affinity Asset Advisors, LLC $113.561.517 1.279.134 1,37% Saham
JPMORGAN CHASE & CO $98.870.628 1.093.026 1,19% Saham
Holocene Advisors, LP $90.126.793 1.015.170 1,09% Saham
MARSHALL WACE, LLP $88.042.506 991.693 1,06% Saham
Polar Capital Holdings Plc $87.715.439 988.009 1,06% Saham
Siren, L.L.C. $85.992.130 968.598 1,04% Saham
Capital International Investors $84.802.301 955.196 1,02% Saham
JANUS HENDERSON GROUP PLC $83.586.597 1.656.164 1,01% Saham
BRAIDWELL LP $78.079.080 879.467 0,94% Saham
Commodore Capital LP $75.177.661 846.786 0,91% Saham
UBS Group AG $74.847.843 843.071 0,90% Saham
NORTHERN TRUST CORP $59.884.685 674.529 0,72% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $57.969.611 652.958 0,70% Saham
Pictet Asset Management Holding SA $55.766.092 628.138 0,67% Saham
EMERALD ADVISERS, LLC $50.376.435 567.430 0,61% Saham
VICTORY CAPITAL MANAGEMENT INC $49.182.345 553.980 0,59% Saham
VANGUARD FIDUCIARY TRUST CO $48.952.315 551.389 0,59% Saham
Candriam S.C.A. $48.454.915 546.312 0,58% Saham
MORGAN STANLEY $44.386.718 499.963 0,54% Saham
VOYA INVESTMENT MANAGEMENT LLC $38.325.793 431.694 0,46% Saham
EMERALD MUTUAL FUND ADVISERS TRUST $35.624.839 401.271 0,43% Saham
SAMLYN CAPITAL, LLC $35.518.659 400.075 0,43% Saham
AMERIPRISE FINANCIAL INC $31.612.960 356.082 0,38% Saham
Integral Health Asset Management, LLC $28.853.500 325.000 0,35% Saham
Woodline Partners LP $27.171.030 306.049 0,33% Saham
JENNISON ASSOCIATES LLC $26.916.321 303.180 0,32% Saham
ADAR1 Capital Management, LLC $25.211.922 283.982 0,30% Saham
BNP PARIBAS FINANCIAL MARKETS $23.075.964 259.923 0,28% Saham
Bank of New York Mellon Corp $21.768.235 245.193 0,26% Saham

Tampilkan semua 277 pemilik institusional →

Aktivis & pemilik 5%+ 2 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×8 pengajuan 23 Juni 2026 9,99% Amandemen Kampanye dewan SEC
Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×3 pengajuan 10 Feb. 2022 · Pengajuan awal Kampanye dewan SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 37 orang dalam · 21 pejabat · 19 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Cameron Turtle Chief Executive Officer 1 Okt. 2026 S 537.540 0 40 $-11.374.650
Jeff Marc Goldberg President and CEO 29 Nov. 2022 A · 0 0 $0
Anthony G. Quinn President & CEO 16 Maret 2022 P 550.540 0 0 $0
David George Lowe CEO and President 20 Maret 2017 A 5.658 0 0 $0
Scott L Burrows Chief Financial Officer 1 Okt. 2026 M 79.762 0 26 $-9.124.219
Jonathan Alspaugh President and CFO 22 Juni 2023 A 165.372 0 0 $0
Charles N York II Chief Financial Officer and VP 14 Feb. 2020 A 34.787 0 0 $0
Leslie Sloan Chief Operating Officer 23 Agu 2022 A · 0 0 $0
Heidy King-Jones Chief Legal Officer and Corporate Secretary 1 Okt. 2026 M 2.845 0 10 $-5.114.431
Sheldon Sloan Chief Medical Officer 1 Juli 2026 M 0 0 11 $-7.354.471
Linda L Neuman Chief Medical Officer 23 Feb. 2023 A · 0 0 $0
James Paul Kastenmayer General Counsel 23 Feb. 2023 A · 0 0 $0
Jr. Michael Conick Hanley Chief Business Officer 23 Feb. 2023 A 36.200 0 0 $0
Steven Weber VP, Controller&Princ Acctg Off 17 Feb. 2022 A · 0 0 $0
Madduri Ravin Rao Chief Medical Officer 14 Feb. 2020 A · 0 0 $0
James Wooldridge Chief Medical Officer 28 Feb. 2019 A · 0 0 $0
Aaron Schuchart Chief Business Officer 28 Feb. 2019 A 2.500 0 0 $0
Scott W Rowlinson VP, Research 22 Agu 2017 A 11.204 0 0 $0
Joseph E Tyler VP, Manufacturing 22 Agu 2017 A 42.428 0 0 $0
Henry Hebel VP, Product Development 20 Maret 2017 A · 0 0 $0
Sandra Rojas-Caro Chief Medical Officer 17 Mei 2016 A · 0 0 $0
Jeffrey W. Albers Direktur 7 Agu 2026 M 9.360 0 3 $-2.404.190
Michael Thomas Henderson Direktur 22 Juni 2026 S 68.606 0 5 $-7.952.050
Sandra Milligan Direktur 27 Mei 2026 A · 0 0 $0
Mark C. Mckenna Direktur 27 Mei 2026 A · 0 0 $0
Laurie Stelzer Direktur 27 Mei 2026 A · 0 0 $0
Hunter C Smith Direktur 22 Juni 2023 A · 0 0 $0
Alison Frances Lawton Direktur 22 Juni 2023 A · 0 0 $0
Russell J. Cox Direktur 22 Juni 2023 A 7.000 0 0 $0
Ivana Magovcevic-Liebisch Direktur 22 Juni 2023 A · 0 0 $0
Marcio Souza Direktur 25 Agu 2022 P 90.000 0 0 $0
Armen Shanafelt Direktur 7 Juni 2022 A 150.000 0 0 $0
Sandesh Mahatme Direktur 7 Juni 2022 A · 0 0 $0
Bryan V Lawlis Direktur 7 Juni 2022 A · 0 0 $0
Suzanne Louise Bruhn Direktur 8 Juni 2020 A · 0 0 $0
George Georgiou Direktur 13 Agu 2018 M 175.861 0 0 $0
Eli Lilly and Company Pemilik 10% 12 April 2016 C 2.568.543 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 36 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
LABU · Direxion Shares ETF Trust 0,89% 44.942 NS 31 Juli 2026 N-PORT
BBC · ETFis Series Trust I 0,82% 3.847 NS 31 Juli 2026 N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 0,77% 710 NS 31 Juli 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0,75% 33.756 SH 2 Okt. 2026 Harian
FDMO · FIDELITY COVINGTON TRUST 0,70% 64.674 NS 31 Juli 2026 N-PORT
ESSC · Strategy Shares 0,55% 2.023 NS 31 Juli 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0,53% 6.226 SH 2 Okt. 2026 Harian
IBB · iShares Trust 0,51% 591.167 SH 11 Sep. 2026 Harian
IWO · iShares Trust 0,43% 700.908 SH 11 Sep. 2026 Harian
VTWG · VANGUARD SCOTTSDALE FUNDS 0,39% 79.707 SH 19 Agu 2026 Harian
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,30% 20.972 NS 31 Juli 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,28% 2.523 NS 31 Juli 2026 N-PORT
PWS · Pacer Funds Trust 0,25% 614 NS 31 Juli 2026 N-PORT
RSSL · Global X Funds 0,24% 35.657 NS 31 Juli 2026 N-PORT
IWM · iShares Trust 0,22% 1.903.999 SH 11 Sep. 2026 Harian
VTWO · VANGUARD SCOTTSDALE FUNDS 0,20% 428.619 SH 19 Agu 2026 Harian
VFMO · VANGUARD WELLINGTON FUND 0,18% 39.684 SH 19 Agu 2026 Harian
ESML · iShares Trust 0,09% 29.173 SH 11 Sep. 2026 Harian
ISCG · iShares Trust 0,08% 8.816 SH 11 Sep. 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,08% 886.783 SH 19 Agu 2026 Harian
FHLC · FIDELITY COVINGTON TRUST 0,08% 26.643 NS 31 Juli 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,07% 568.910 SH 19 Agu 2026 Harian
VHT · VANGUARD WORLD FUND 0,07% 168.446 SH 19 Agu 2026 Harian
PRFZ · Invesco Exchange-Traded Fund Trust 0,06% 17.397 SH 2 Okt. 2026 Harian
WSML · iShares Trust 0,05% 3.911 SH 11 Sep. 2026 Harian
VB · VANGUARD INDEX FUNDS 0,04% 896.639 SH 19 Agu 2026 Harian
TILT · FlexShares Trust 0,02% 4.212 NS 31 Juli 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,01% 2.482.796 SH 19 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 6.117 SH 19 Agu 2026 Harian
ITOT · iShares Trust 0,01% 103.097 SH 11 Sep. 2026 Harian
IWV · iShares Trust 0,01% 20.075 SH 11 Sep. 2026 Harian
PTH · Invesco Exchange-Traded Fund Trust 0,00% 91 SH 2 Okt. 2026 Harian
ISCB · iShares Trust · 3.478 SH 11 Sep. 2026 Harian
ISCV · iShares Trust · 10.938 SH 11 Sep. 2026 Harian
SMLF · iShares Trust · 37.682 SH 11 Sep. 2026 Harian
SMMV · iShares Trust · 1.644 SH 1 Sep. 2026 Harian

SYRE Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 23 analis BELI
Target median $121.00 +29,8%
11 47,8% Beli Kuat
10 43,5% Beli
2 8,7% Tahan
0 0,0% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

13 analis · 2026-09-30

Target rata-rata $120.08 +28,9%

← Di bawah semua target Harga saat ini $93.19
Rendah$97.00 Rata-rata$120.08 Tinggi$130.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
SYRE $2.56B 10.1 -62.0% · -26.5% ·
KYMR $6.33B -21.1 -16.7% -794.0% -24.4% ·
PCVX $6.05B -8.2 · · -26.6% ·
TGTX $4.63B 10.8 87.3% 72.6% 96.7% ·
PRAX $7.43B -21.9 249.5% · -47.3% ·
CAI $7.62B -8.4 97.0% -8.4% -13.2% ·
IONS $12.92B -33.2 · · -68.1% ·
IMVT $5.07B -9.0 229.2% · -73.7% ·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23
Sinyal atau Kebisingan: Apa Arti Pembelian Spyre Therapeutics oleh Penasihat VR bagi Para Bodoh Nasdaq · 6 bulan, 2 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Agu 4, 2026